A phase I/II study of percutaneous radiofrequency ablation for malignant tumor in the pelvis (JIVROSG-0204)
Not Applicable
- Conditions
- Symptomatic intrapelvic malignant tumor
- Registration Number
- JPRN-C000000046
- Lead Sponsor
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 33
Inclusion Criteria
Not provided
Exclusion Criteria
1) No symptom or VAS of less than 3. 2) Cardiac pacemaker. 3) Artery or nerve along the puncture route. 4) Lesion or target area adjacent to critical organs. 5) Infection in the target area. 6) Pregnancy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adverse events
- Secondary Outcome Measures
Name Time Method Improvement of symptom measured by Visual Analogue Scale at 1 week after the procedure.